BioRestorative Therapies issues Q1 2025 results press release; financial details not available

BioRestorative Therapies, Inc.

2025-Q1 EPS reported -$0.64 revenue$25,000

Company announced Q1 2025 financial results and business update on May 14, 2025.
Press release references a conference call to discuss results, but specific figures are not included in the filing.
No EPS, revenue, or segment data were disclosed in the submitted Form 8-K exhibits.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.